GLP-1 RA Use in Atopic Dermatitis May Reduce Long-Term MACE Risk - The Cardiology Advisor

GLP-1 RA Use in Atopic Dermatitis May Reduce Long-Term MACE Risk  The Cardiology AdvisorGLP-1 Receptor Agonists Reduce Cardiovascular Risk Among Atopic Dermatitis Patients, Suggests Study  Medical DialoguesGLP-1s Show Promise in Reducing Heart Risk in ARDs  emjreviews.com